Adapting the Bellmunt Risk Score for Prognostic Stratification in Metastatic Castration‐Sensitive Prostate Cancer
The Bellmunt risk score appears to offer a practical approach to risk stratification in mCSPC, with promising prognostic value across treatment types. However, its incremental clinical utility over existing criteria is limited, and its role in guiding therapy remains unestablished. These exploratory findings warrant prospective validation.
Authors
- Satı Coşkun Yazgan
- Hatice Bölek (ORCID: https://orcid.org/0000-0001-8659-7327)
- Muharrem Coşkunpınar (ORCID: https://orcid.org/0000-0003-2603-9395)
- Yüksel Ürün (ORCID: https://orcid.org/0000-0002-9152-9887)
- Emre Yekedüz (ORCID: https://orcid.org/0000-0001-6819-5930)
Institutions
- Harvard University (US)
- Ankara University (TR)
- Dana-Farber Cancer Institute (US)
Publication Details
- Journal
- The Prostate
- Published
- 2025-09-24
- DOI
- https://doi.org/10.1002/pros.70062
- Citations
- 1
- Primary Topic
- Prostate Cancer Treatment and Research
- Type
- article
- Field-Weighted Citation Impact
- 1.52